Literature DB >> 602235

Immunotherapy of human malignancies with immune RNA.

J B DeKernion, K P Ramming, Y H Pilch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 602235     DOI: 10.1007/bf01556192

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  28 in total

1.  Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.

Authors:  S R Waldman; J A Roth; D H Kern; Y H Pilch
Journal:  J Lab Clin Med       Date:  1975-12

2.  Complete and apparently specif local tumor regression using syngeneic or xenogeneic "tumor-immune" RNA extracts.

Authors:  S I Schlager; R E Paque; S Dray
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

3.  Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.

Authors:  F R Eilber; D L Morton; E C Holmes; F C Sparks; K P Ramming
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

4.  Immune cytolysis of human neoplasms mediated by RNA.

Authors:  P A Brower; K P Ramming; J B deKernion
Journal:  Surg Forum       Date:  1975

5.  Transformation of nonimmune lymph node cells to state of transplantation immunity by RNA. A preliminary report.

Authors:  J A MANNICK; R H EGDAHL
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

6.  Experimental models and the role of RNA in immunotherapy of leukemia.

Authors:  R Ono; K Esaki; Y Kodera; H Shiku; K Yamada
Journal:  Ann N Y Acad Sci       Date:  1973-05-31       Impact factor: 5.691

7.  Mediation of immunity to tumor-specific transplantation antigens by RNA inhibition of isograft growth in rats.

Authors:  P J Deckers; Y H Pilch
Journal:  Cancer Res       Date:  1972-04       Impact factor: 12.701

8.  Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.

Authors:  D H Kern; C R Drogemuller; N Chow; D D Holleman; Y H Pilch
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

9.  RNA-mediated transfer of tumor immunity--a new model for the immunotherapy of cancer.

Authors:  P J Deckers; Y H Pilch
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

10.  Hormonal treatment of metastases of renal carcinoma.

Authors:  B van der Werf-Messing; H A van Gilse
Journal:  Br J Cancer       Date:  1971-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.